ResMed to Report Q4 Results on August 6

Earnings
โดย RTTNews·Read original
Summary · why it matters

ResMed will release its fourth quarter results on August 6, 2026, after the New York Stock Exchange close, followed by a webcast. In the third quarter of 2026, net revenue rose 10.8% to $1.43 billion, driven by Sleep and Breathing segment net sales of $1.26 billion and Residential Care Software net sales of $0.17 billion. Net income increased 9.2% to $0.39 billion, with earnings per share of $2.74. For the fourth quarter of 2025, consolidated net revenue grew 10.2% to $1.34 billion, with Sleep and Breathing net sales of $1.18 billion and Residential Care Software net sales of $0.17 billion. ResMed shares closed Wednesday at $201.10, up 3.19%, and are currently trading up 2.12% to $205.37.

Impact on stocks 1

Cloud & Digital Infrastructure▲ · 1 stocks
ResMed Inc
RMD
± MixedCapitalrelevance

Article only announces upcoming Q4 results date and recaps past performance; no new substantive news.

© 2026 MarketDXNews